Nationwide Italian registry reveals who responds best to rituximab in NMOSD and MOGAD
A 664-patient Italian registry study identifies sex and onset phenotype as predictors of rituximab response in AQP4-positive NMOSD and MOGAD.
A 664-patient Italian registry study identifies sex and onset phenotype as predictors of rituximab response in AQP4-positive NMOSD and MOGAD.
A reciprocal cross study in Drosophila shows that paraquat resistance linked with extended longevity is heritable across generations, with maternal ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.